We organize and sponsor international workshops to facilitate one of the key missions of the BioMed21 collaboration – to bring relevant players together in order to identify opportunities, acknowledge existing barriers, and make recommendations necessary for implementation of a human biology platform for biomedical research. Here you can learn about our events: the speakers, their presentations, and formal accounts of the workshops, including our published workshop reports.
UPCOMING
26th June, 2021 (Saturday) – Time: 11 AM (IST)
Webinar Series: Developing Human Relevant Research in India – Part 10
In Vitro 3D Osteochondral Model for Drug Screening
Speaker: Dr. Biman Mandal, Professor, Dept of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati
PAST EVENTS
August 2020-April 2021
Webinar Series: Developing Human Relevant Research in India
- Part 1: Microphysiological Systems
- Part 2: Systems Biology & Pharmacology
- Part 3: Computational Tools & Biological Networks
- Part 4: Understanding Cancer Using Microphysiological Systems
- Part 5: Virtual Demonstration of Organ-on-Chip / Understanding Polycystic Kidney Disease Using Kidney-on-Chip
- Part 6: Use of In-vitro Human Surrogate Models – An Industry Perspective
- Part 7: Use of Human Clinical Samples to build Microphysiological System Models
- Part 8: Tissue Engineering and MPS models
- Part 9: Brain Organoids
* Humane Society International, co-founder of the BioMed21 Collaboration, co-organized the webinar series.
2021 – March
Online Symposium (Korea): 3D Tissue chip and MPS, from development to regulatory adaptation.
AGENDA »
Microphysiological systems – from scientific models towards industrial adaptation of qualified assays and their regulatory acceptance
Uwe Marx, CSO & Founder, TissUse, Germany
US interagency OOC development program: from funding to qualification for regulatory acceptance
Suzanne Fitzpatrick, FDA, US
Introducing new legislative effort, Act on the promotion of development, distribution and use of alternatives to animal testing
Borami Seo, Interim ED, Senior Policy Manager, Humane Society International, Korea
Industry’s role for OOC development and regulatory applications
Adrian Roth, Roche, Switzerland
2020 – June
National Assembly Forum to Discuss the Proposed Promotion of Alternatives to Animal Methods Act
National Assembly, Seoul, South Korea
2019 – May
BioMed21: Science Without Animal Use
National Assembly, Seoul, South Korea
2019 – April
Cosmetic Risk Assessment and Regulatory Application of Non-animal Testing Technology
Shanghai, China
2019 – March
Humane Society International Symposium on Global Harmonization of Vaccine Testing Requirements
Rome, Italy
2018 – November
National Conference on Alternatives to Animal Experiments
Jamia Hamdard, New Delhi, India
2018 – October
2nd Asian Congress on Alternatives*
Guangzhou, China
- Agenda
- BioMed21 presentation by Catherine Willett
- AOP continuing education course
- Press release
* Humane Society International, co-founder of the BioMed21 Collaboration, is a founding co-organizer and sponsor of the Asian Congress on Alternatives and of the annual Chinese Conferences on Toxicological Alternatives and Translational Toxicology.
2018 – June
China’s 8th Workshop on Alternative Methods*
Shanghai, China
- Agenda
- Presentations
* Humane Society International, co-founder of the BioMed21 Collaboration, co-sponsored China’s 8th Workshop on Alternative Methods
2017 – June
BioMed21: A Human Pathways Approach to Disease Research
National Institutes of Health, Bethesda, Maryland, United States
- Agenda
- Presentations
- Flash report
- Organizing Committee: Chris Austin (NCATS/NIH), Brian Berridge (GSK), Warren Casey (NIEHS/NIH), Suzy Fitzpatrick (FDA), Robert Kavlock (EPA), Troy Seidle (HSI), Anton Simeonov (NCATS/NIH), Dan Tagle (NCATS/NIH), Catherine Willett (HSUS/HSI)
- Final report
2017 – May
BioMed21: Emerging Technology Toward Pathway Based Human Brain Research
D’Or Institute, Rio de Janeiro, Brazil
2015 – December
BioMed21: A Human Pathways Approach to Disease Research
Brussels, Belgium
